An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Twist Bioscience to Present at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Twist Bioscience Corporation (NASDAQ: TWST) announced that CEO Emily M. Leproust, Ph.D., and CFO Jim Thorburn will present at two upcoming investor conferences. They will speak at the William Blair Growth Stock Conference on June 9 at 1:20 p.m. CT in Chicago, and at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14 at 10:40 a.m. PT in Rancho Palos Verdes. Both presentations will be webcast live and available for replay on the company's investor relations website for 30 days.
Positive
None.
Negative
None.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming investor conferences:
William Blair Growth Stock Conference on Thursday, June 9 in Chicago; presentation at 1:20 p.m. Central Time.
Goldman Sachs 43rd Annual Global Healthcare Conference on Tuesday, June 14 in Rancho Palos Verdes; fireside chat at 10:40 a.m. Pacific Time.
The presentations will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the presentations will be archived for a period of 30 days following the conclusion of the live events.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
When will Twist Bioscience present at the William Blair Growth Stock Conference?
Twist Bioscience will present at the William Blair Growth Stock Conference on June 9 at 1:20 p.m. Central Time.
What is the date and time of Twist Bioscience's presentation at the Goldman Sachs Global Healthcare Conference?
The presentation at the Goldman Sachs 43rd Annual Global Healthcare Conference is scheduled for June 14 at 10:40 a.m. Pacific Time.
Where can I access the live webcast of Twist Bioscience's presentations?
The live webcast of Twist Bioscience's presentations can be accessed on the company's investor relations website under the 'Investor Calendar' section.
Will the presentations by Twist Bioscience be available for replay?
Yes, the presentations will be archived and available for replay for 30 days following the live events.
What are the key products of Twist Bioscience?
Twist Bioscience specializes in synthetic DNA products, including synthetic genes, NGS preparation tools, and antibody libraries for drug discovery.
